Current application status and structure–activity relationship of selective and non-selective JAK inhibitors in diseases
Tong Li, Xianjing Yang, Juan Zhu, Ying Liu, Xiaobao Jin, Gong Chen, Lianbao Ye
Topics & Concepts
Janus kinaseJAK-STAT signaling pathwayTyrosine kinase 2statCancer researchJanus kinase 1RuxolitinibMedicineTyrosine kinaseSignal transductionBiologyPharmacologyCytokineReceptorImmunologySTAT3Internal medicineGeneticsPlatelet-derived growth factor receptorGrowth factorMyelofibrosisBone marrowCytokine Signaling Pathways and InteractionsPharmacological Effects of Natural CompoundsRheumatoid Arthritis Research and Therapies